Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.

Barbier E, Höglund L, Xu L, Salem NA, Osterndorff-Kahanek EA, Barchiesi R, Lacorte A, Fenno LE, Messing RO, Mayfield RD, Heilig M

Open source

DOI: 10.1038/s41467-026-77302-9
Published: 2026 Sep 2
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-77302-9,
  title = {Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.},
  author = {Barbier E and Höglund L and Xu L and Salem NA and Osterndorff-Kahanek EA and Barchiesi R and Lacorte A and Fenno LE and Messing RO and Mayfield RD and Heilig M},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-77302-9},
  url = {https://doi.org/10.1038/s41467-026-77302-9}
}

RIS

TY  - JOUR
TI  - Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.
AU  - Barbier E
AU  - Höglund L
AU  - Xu L
AU  - Salem NA
AU  - Osterndorff-Kahanek EA
AU  - Barchiesi R
AU  - Lacorte A
AU  - Fenno LE
AU  - Messing RO
AU  - Mayfield RD
AU  - Heilig M
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-77302-9
UR  - https://doi.org/10.1038/s41467-026-77302-9
ER  -

APA

E, B., L, H., L, X., NA, S., EA, O., R, B., A, L., LE, F., RO, M., RD, M., & M, H. (2026). Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.. Nature communications. https://doi.org/10.1038/s41467-026-77302-9

Source records

pubmed · retrieved 2026-09-25T14:45:14.228Z